global colorectal cancer drugs market 2015-2019
TRANSCRIPT
Covered in this Report• This report covers the present scenario and the
growth prospects of the global colorectal cancer drugs market for the period 2015-2019.
• To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of colorectal cancer.
• The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors as well as the competitive performances of their product portfolios in the market.
• In addition, it discusses the major drivers that influence the growth of the market.
• Technavio's report, Global Colorectal Cancer Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
Global Colorectal Cancer Drugs Market
2015-2019
USA – CANADA – UK – CHINA – INDIA
Market Overview
• Colorectal cancer refers to malignancies that originate in the rectum or the colon.
• It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer.
• The cancer starts as a polyp in the inner wall of the colon or rectum.
• These polyps can be benign or malignant.
• Colorectal cancer is the third most common cancer in the US.
• Technavio's analysts forecast the global colorectal cancer drugs market to grow at a CAGR of 3.62% over the period 2014-2019.
To know more aboutGlobal Colorectal
Cancer Drugs Market 2015-2019,
please mail us [email protected]
USA – CANADA – UK – CHINA – INDIA
Key Vendors and Regions
• Amgen
• Bayer
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• Merck Serono
• Accord Healthcare
• Advenchen Laboratories
• Aeterna Zentaris
• AstraZeneca
View Our Report: Global Colorectal Cancer Drugs Market 2015-2019
• Americas
• APAC
• EMEA
Vendors Regions
USA – CANADA – UK – CHINA – INDIA
Key Findings
USA – CANADA – UK – CHINA – INDIA
• Biologics are rapidly becoming the treatment of choice for colorectal cancer.
• Biologics are targeted therapy, which act only on the malignant cells and do not attack the healthy cells.
• The major biologics used for treating colorectal cancer include Erbitux (cetuximab), Zaltrap (ziv-Aflibercept), Avastin (bevacizumab), and Vectibix (panitumumab).
• These biologics together accounted for the major share of the market, and the same trend is expected to continue during the forecast period.
• Vendors are increasingly forming strategic alliances to increase their market shares.
• Growing awareness about colorectal cancer increases the sales and use of the drugs.
Key Questions Answered in Our Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Have a question of your own about this report?
Ask our Analysts
USA – CANADA – UK – CHINA – INDIA
• Decision makers and influencers in sales & marketing, strategy, product and R&D teams rely on research from Technavio. We have a large and growing base of happy customers worldwide. Our customers include technology suppliers, end users, consulting companies, investment firms and research institutes.
• Technavio was founded in 2003 in London. We have about 300 analysts globally. We cover more than 500 technologies across 80 countries. Traditional media such as Forbes Asia and New York Times, along with other web media portals, like to quote us.
About Technavio
Some of our clients include:ACT Global, Flextronics, Huawei Technologies Co, Infosys, Harris Corporation, Infosys, Intercad, Hidaka Precision Tools & Dies Company, Huawei Technologies Co, American Capital, Analysis Group, Netscout, NTT DoCoMo
USA – CANADA – UK – CHINA – INDIA
View Our Report
Global Colorectal Cancer Drugs Market 2015-2019
109 Pages | SKU: IRTNTR6118
For media enquiries,
please drop us a mail at
For more on the scope of the report, mail us at
Thank You!
Mail us at: [email protected] can visit us at:www.technavio.com
USA – CANADA – UK – CHINA – INDIA